GlassScriptPhysician profile
Najeeb Ahmed
NPI 1972574275
$15,714.54
in general payments reported to CMS, 2019-2025
23 companies · $322 in 2025
The $322 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,704 · 2020: $2,863 · 2021: $447 · 2022: $3,132 · 2023: $3,736 · 2024: $510 · 2025: $322.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,152 · Food and Beverage: $1,416.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,151.96 |
| Food and Beverage | $1,416.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $2,967.31 | 2019-2023 | |
| Medtronic Vascular, INC. | $2,959.93 | 2019-2020 | |
| Penumbra, INC. | $2,605.98 | 2023-2024 | Indigo System |
| Philips North America LLC | $1,633.53 | 2020 | |
| Abbott Laboratories | $1,162.43 | 2019-2025 | Diamondback Coronary, Cardiomems |
| Abiomed | $955.60 | 2019-2025 | Impella |
| Terumo Medical Corporation | $870.74 | 2019-2023 | Glidesheath Slender |
| Medtronic, INC. | $799.30 | 2021-2025 | Abre, Mycarelink, Hawkone |
| Janssen Pharmaceuticals, INC | $555.80 | 2019-2023 | Xarelto |
| Cardiovascular Systems INC. | $239.10 | 2019-2021 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $237.06 | 2021-2025 | Lifevest |
| Novartis Pharmaceuticals Corporation | $193.85 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $111.02 | 2021-2022 | |
| Shockwave Medical, INC | $79.76 | 2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Stryker Corporation | $74.44 | 2025 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Angiodynamics, INC. | $58.25 | 2021 | |
| Amgen INC. | $52.89 | 2022-2024 | Repatha |
| Pfizer INC. | $49.70 | 2023-2025 | |
| Astellas Pharma US INC | $38.47 | 2019 | |
| Novo Nordisk INC | $22.90 | 2025 | Ozempic |
| Ge Healthcare | $17.84 | 2021 | |
| Bard Peripheral Vascular, INC. | $15.06 | 2023 | Rotarexs 6 F X 135 Cm |
| Actelion Pharmaceuticals US, INC. | $13.58 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Najeeb Ahmed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.